PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 10, 2025Asian Journal of Internal Medicine0 citationsOpen Access

Hypereosinophilic syndrome associated with idiopathic eosinophilic vasculitis

View Full Paper
SBSubhani BrabaharanBYB. M. A. C. YashodaraMSM. Sivapalan

Key Points

  • A 46-year-old woman presented with hypereosinophilia and symptoms of eosinophilic vasculitis, leading to treatment with imatinib.
  • Initial glucocorticoid treatment failed, but long-term imatinib led to symptom resolution, highlighting potential for better management.
  • Differentiating hypereosinophilic syndrome with cutaneous vasculitis from other conditions is crucial for effective treatment.
  • This case calls attention to the need for awareness of HES in patients displaying dermal oedema and rash without significant systemic symptoms.

Abstract

Hypereosinophilic syndrome (HES) is a complex heterogenous syndrome associated with hypereosinophilia and end organ involvement. A 46-year-old woman presented with swelling of the upper and lower limbs, neck and face, with shortness of breath. On examination there was evidence of dermal oedema with an urticarial rash. Investigations revealed high absolute eosinophil count, evidence of cutaneous vasculitis and increased bone marrow eosinophilic precursors. There was no other end-organ involvement. There was a recurrence of symptoms despite an initial course of glucocorticoids. However, she later responded to long-term imatinib. This case highlights the importance of considering HES with idiopathic cutaneous vasculitis even in the absence of significant systemic involvement.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Brabaharan et al. (2025) studied this question.

synapsesocial.com/papers/68c1d24654b1d3bfb60f8620https://doi.org/10.4038/ajim.v4i2.298
Ask AI
Helpful
Bookmark
Share
View Full Paper